Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth B Margulies

Showing results (191-200 of 265) with videos related to

Pageof 27
Sort By:
ESC Heart Failure|December 2, 2020
The effect of transfusion of blood products on ventricular assist device support outcomesSupriya Shore, Thomas C Hanff, Jeremy A Mazurek, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 29, 2022
Aortic Cellular Diversity and Quantitative Genome-Wide Association Study Trait Prioritization Through Single-Nuclear RNA Sequencing of the Aneurysmal Human AortaElizabeth L Chou, Mark Chaffin, Bridget Simonson, et al.
Circulation Research|November 19, 2016
Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized TrialJaved Butler, Stephen E Epstein, Stephen J Greene, et al.
European Heart Journal|February 3, 2023
Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respirationEdgar E Nollet, Inez Duursma, Anastasiya Rozenbaum, et al.
JAMA|August 3, 2016
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialKenneth B Margulies, Adrian F Hernandez, Margaret M Redfield, et al.
Circulation. Heart Failure|May 5, 2020
Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT TrialBrahim Redouane, Stephen J Greene, Marat Fudim, et al.
Circulation|October 26, 2020
Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point ResultsEmma J Birks, Stavros G Drakos, Snehal R Patel, et al.
Journal of Cardiac Failure|July 26, 2015
Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart FailureJustin L Grodin, Susanna R Stevens, Lisa de las Fuentes, et al.
Circulation. Heart Failure|June 7, 2014
A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathyJeffrey E Cohen, Brendan P Purcell, John W MacArthur, et al.
Circulation Research|December 4, 2025
Increased CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress that Suppresses Gene Programs for Remodeling and Enables Rescue by Gene TransferAndrew N Carley, Santosh K Maurya, Chandan K Maurya, et al.
Pageof 27

Showing results (191-200 of 265) with videos related to

Sort By:
Pageof 27
ESC Heart Failure|December 2, 2020
The effect of transfusion of blood products on ventricular assist device support outcomesSupriya Shore, Thomas C Hanff, Jeremy A Mazurek, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 29, 2022
Aortic Cellular Diversity and Quantitative Genome-Wide Association Study Trait Prioritization Through Single-Nuclear RNA Sequencing of the Aneurysmal Human AortaElizabeth L Chou, Mark Chaffin, Bridget Simonson, et al.
Circulation Research|November 19, 2016
Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized TrialJaved Butler, Stephen E Epstein, Stephen J Greene, et al.
European Heart Journal|February 3, 2023
Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respirationEdgar E Nollet, Inez Duursma, Anastasiya Rozenbaum, et al.
JAMA|August 3, 2016
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialKenneth B Margulies, Adrian F Hernandez, Margaret M Redfield, et al.
Circulation. Heart Failure|May 5, 2020
Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT TrialBrahim Redouane, Stephen J Greene, Marat Fudim, et al.
Circulation|October 26, 2020
Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point ResultsEmma J Birks, Stavros G Drakos, Snehal R Patel, et al.
Journal of Cardiac Failure|July 26, 2015
Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart FailureJustin L Grodin, Susanna R Stevens, Lisa de las Fuentes, et al.
Circulation. Heart Failure|June 7, 2014
A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathyJeffrey E Cohen, Brendan P Purcell, John W MacArthur, et al.
Circulation Research|December 4, 2025
Increased CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress that Suppresses Gene Programs for Remodeling and Enables Rescue by Gene TransferAndrew N Carley, Santosh K Maurya, Chandan K Maurya, et al.
Pageof 27